Trial intelligence / Profile preview

Acute Effects of Alcohol on PET Imaging of PDE4B

NCT07027839Phase 1Recruiting

Sponsor
National Institute of Mental Health
Start
Dec 2025
Primary completion
Feb 2028
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of ethanol in alcohol use disorder (AUD), sponsored by National Institute of Mental Health. Primary endpoint: Distribution Volume (VT) of PDE4B Binding at 36 months. Started Dec 2025; status: recruiting.

02

Drugs

ethanol
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT07027839.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07027839.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call